Skip to main content View accessibility support page
  • Study
  • Research
  • Faculties
  • News
  • Events
  • About
  • Get involved
  • Giving
  • Shop Imperial
  • Search

Website navigation

Skip to section navigation

Global site navigation

  • Study
    • Course search
    • Apply
    • Fees and funding
    • Student life
    • Visit
    • Help centre
    • Request info
    • International students
    • Executive education
    • Summer schools
  • Research
  • Faculties
    • Faculty of Engineering
    • Faculty of Medicine
    • Faculty of Natural Sciences
    • Imperial Business School
    • Administrative and support services
  • News
    • News
    • Imperial Stories
    • Imperial Magazine
  • Events
    • What's on
    • Great Exhibition Road Festival
    • Imperial Lates
    • Graduation
  • About
    • President
    • Provost and Deputy President
    • Council
    • Imperial Strategy
    • Imperial Global
    • Sustainable Imperial
    • School of Convergence Science
    • Governance
    • Campuses
    • Our academics
    • Jobs at Imperial
  • Get involved
    • Giving
    • Schools outreach
    • Imperial Global Summer School
    • Societal engagement
    • Volunteering and outreach
    • Women at Imperial
  • Giving
  • Shop Imperial

User links navigation

  • For staff
  • Current students
  • Imperial for business
  • For schools
  • Alumni
Commercialisation

Imperial.Tech navigation

  • Technology search
  • Our team
    • Marika Reay
    • James Chan
    • Heather Barcombe
    • Anne Roques
    • Laura Cabo-Fernandez
    • Miguel Cheng
    • Fauzia Farooq
    • Valeska Gonzalez
    • Luis A Gomez Sarosi
    • Jialuo Luo
    • Ryhan Miah
    • Louie Scott
    • Conor Simpson
    • Rachel Spruce
    • Edmond Yau
Imperial.Tech

Search Imperial Technologies

Search imperial technology

Showing 80 results

A novel targeted drug delivery system

RBCV-based system enables targeted, stable thrombolytic drug delivery to clots, reducing bleeding risks in thrombosis treatment.

Human monoclonal antibodies to COVID-19

Broad neutralising monoclonal antibodies identified for SARS-CoV-2, enabling therapeutic strategies against coronaviruses.

EffiTrap: comprehensive and real-time defect analysis for semiconductors

Technology for advanced defect analysis in semiconductors, sensors, photonics, laser materials, and photovoltaics.

Long-lasting nanoparticles for controlled release drug delivery

A nanoparticle drug platform that can deliver small molecule drugs over a sustained period in a stable, low-toxic manner.

Two-gene signature diagnostic test for differentiating between viral and bacterial infections in children

A simple, whole blood 2-gene expression signature that distinguishes bacterial infection from both viral infection and childhood inflammatory diseases.

MicroRNA plasma markers for small-for-gestational-age (SGA) births

Non-invasive blood test detects placental miRNAs at 13 weeks to predict small-for-gestational-age births, improving prenatal outcomes.

MicroRNA Biomarkers for ectopic or intrauterine pregnancy

Blood-based microRNA markers predict ectopic or non-viable pregnancies early, improving diagnosis and treatment before ultrasound confirmation.

MyoLoop for cardiovascular research

MyoLoop is a device that simulates the synchronised mechanical and electrical events that occur in the heart inside the body (in vivo), on an in vitro heart model known as myocardial slice.

Machine learning tool stratifying early and late Alzheimer’s disease (ApV)

MRI-based tool uses radiomics and AI to accurately detect and stratify Alzheimer’s and MCI, improving early diagnosis and trials.

anti-TCRVbeta Chimeric Antigen Receptors (CARs)

A chimeric antigen receptor (CAR) construct specific for a T-cell receptor (TCR) beta-chain variable region subunit of a T cell.

Gene expression signature to diagnose multiple infectious & inflammatory diseases in children

A gene expression signature capable of simultaneous diagnosis of multiple diseases in children. The technology can detect 18 different infectious and inflammatory diseases in children that present with similar symptoms.

Media for the growth of Lactobacillus Iners

A novel growth medium for the culture of Lactobacillus iners to unprecedented high cell densities within 24 hours.

  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Contact and Links

Contact Imperial
Technologies

Imperial Technologies

Search Technologies

Our team

Find us on social media

  • X, formerly known as Twitter
  • LinkedIn

Useful Links

Popular links

  • Blackboard
  • Contact the Service Desk
  • Jobs
  • Library services
  • Outlook email online

Faculties

  • Engineering
  • Medicine
  • Natural Sciences
  • Imperial Business School

Directories

  • Admin and support services
  • Networks and Centres
  • Research groups
  • Search all staff

Partners

  • Imperial College Academic Health Science Centre
  • Imperial College Health Partners
  • Imperial College Healthcare NHS Trust
  • Imperial Consultants

College Information

Imperial College London

Address

Imperial College London
South Kensington Campus
London SW7 2AZ, UK
tel: +44 (0)20 7589 5111

Facebook X, formerly known as Twitter YouTube LinkedIn Instagram TikTok TikTok

Site Information

  • Sitemap
  • Accessibility
  • Modern slavery statement
  • Privacy notice
  • Use of cookies
  • Report incorrect content
  • Log in

© 2026 Imperial College London